LoadingNIVF
Fong Hei Yue Tina reported Exercise or conversion in NewGenIvf Group Ltd: 139811 units of Class B Ordinary Shares, dated 2026-10-05. The full Form 4 contains 3 transaction entries.
NIVF
Siu Wing Fung Alfred reported Exercise or conversion in NewGenIvf Group Ltd: 139811 units of Class B Ordinary Shares, dated 2026-10-05. The full Form 4 contains 3 transaction entries.
AEF
Clark Anthony S. reported Purchase in abrdn Emerging Markets ex-China Fund, Inc.: 2000 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
VYLR
O'Connor Judd M reported Other (see filing) in Vylor Inc.: 92768.8636 units of Common, dated 2026-10-01. The full Form 4 contains 7 transaction entries.
VYLR
Eathington Samuel R reported Other (see filing) in Vylor Inc.: 152325.2906 units of Common, dated 2026-10-01. The full Form 4 contains 7 transaction entries.
AXIA3
Falconi Campos Vicente reported Grant or award in AXIA Energia S.A.: 1464 units of Common Shares, dated 2026-10-02. The full Form 4 contains 6 transaction entries.
UXIN
Dai Kun reported Purchase in Uxin Ltd: 8683 units of American depositary shares, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
AFL
Japan Post Holdings Co., Ltd. reported Sale in AFLAC INC: 5671 units of Common Stock, dated 2026-10-02. The full Form 4 contains 2 transaction entries.
TMP
Coletti Janet M. reported Grant or award in TOMPKINS FINANCIAL CORP: 19.71 units of Phantom Stock (derivative), dated 2026-10-02. The full Form 4 contains 1 transaction entry.
LSAK
Kola Naeem Ebrahim reported Disposition to issuer in LESAKA TECHNOLOGIES INC: 68319 units of Common Stock, dated 2025-12-01. The full Form 4 contains 1 transaction entry.
LAES
Pellaton Eric Adrien reported Grant or award in SEALSQ Corp: 10747 units of Employee Stock Option Plan (right to buy) (derivative), dated 2026-09-25. The full Form 4 contains 2 transaction entries.
LAES
Fergusson David Alexander reported Grant or award in SEALSQ Corp: 3424 units of Employee Stock Option Plan (right to buy) (derivative), dated 2026-09-25. The full Form 4 contains 2 transaction entries.
MGRX
Hamilton Alex P. reported 100,000 shares of Common Stock in MANGOCEUTICALS, INC. as grants or awards dated 2026-07-28. The Form 4 was disclosed on Oct 6, 2026. These were stock awards, not open-market purchases.
MGRX
JOHNSTON EUGENE M reported 100,000 shares of Common Stock in MANGOCEUTICALS, INC. as grants or awards dated 2026-07-28. The Form 4 was disclosed on Oct 6, 2026. These were stock awards, not open-market purchases.
RDHL
Raday Gilead reported Sale in RedHill Biopharma Ltd.: 14310000 units of Ordinary Shares, dated 2026-10-01. The full Form 4 contains 2 transaction entries.
IDCC
Pankaj Rajesh reported Sale in InterDigital, Inc.: 1500 units of Common Stock, dated 2026-10-05. The full Form 4 contains 1 transaction entry.
PRE
Leogrande Hudson Blake reported Exercise or conversion in Prenetics Global Ltd: 2000 units of Class A Ordinary Share, par value $0.0015 per share, dated 2026-10-04. The full Form 4 contains 2 transaction entries.
ASTH
Basho Chandan reported Tax/exercise withholding in Astrana Health, Inc.: 2092 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.
Roth Erin Jennifer reported Other (see filing) in Platinum SpinCo, Inc.: 5266 units of Common Stock, par value $0.001 per share, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
Patten Jeremy Michael reported Other (see filing) in Platinum SpinCo, Inc.: 1023 units of Common Stock, par value $0.001 per share, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
MODINE MANUFACTURING CO reported Other (see filing) in Platinum SpinCo, Inc.: 53197549 units of Common Stock, par value $0.001 per share, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
Lucareli Michael B reported Other (see filing) in Platinum SpinCo, Inc.: 89567 units of Common Stock, par value $0.001 per share, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
Jacobs Stephen Craig reported Purchase in Morgan Stanley Private Markets & Alternatives Fund - Growth: 10000 units of Shares of Beneficial Interest, dated 2025-10-02. The full Form 4 contains 1 transaction entry.
XIVYX
Ghodoosi Arash reported Purchase in Institutional Investment Strategy Fund: 7.652 units of Institutional Investment Strategy Fund - Founder Class Share, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
